Results 41 to 50 of about 244,951 (379)

Depression and Mania in Bipolar Disorder

open access: yesCurrent Neuropharmacology, 2017
: Background: Episode duration, recurrence rates, and time spent in manic and depressive phases of bipolar disorder (BD) is not well defined for subtypes of the disorder.
L. Tondo, G. Vázquez, R. Baldessarini
semanticscholar   +1 more source

Antidepressant treatment-emergent affective switch in bipolar disorder: a prospective case-control study of outcome Ciclagem afetiva associada a tratamento com antidepressivo no transtorno bipolar: estudo caso-controle prospectivo

open access: yesBrazilian Journal of Psychiatry, 2006
OBJECTIVE: Treatment-emergent affective switch has been associated to cycle acceleration and poorer outcome, but there are few studies addressing this issue.
Renata Sayuri Tamada   +4 more
doaj   +1 more source

Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies

open access: yesExperimental and Molecular Medicine, 2018
Bipolar disorder (BD) is a common psychiatric disorder characterized by recurrent mood swings between depression and mania, and is associated with high treatment costs.
Yeunkum Lee   +3 more
semanticscholar   +1 more source

Blue‐blocking glasses as additive treatment for mania: a randomized placebo‐controlled trial

open access: yesBipolar Disorders, 2016
The discovery of the blue lightsensitive retinal photoreceptor responsible for signaling daytime to the brain suggested that light to the circadian system could be inhibited by using blue‐blocking orange tinted glasses.
Tone E G Henriksen   +9 more
semanticscholar   +1 more source

A combined marker of inflammation in individuals with mania. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Markers of immune activation have been associated with mania but have not been examined in combination. We studied the association between mania and an inflammation score based on four immune markers.
Faith Dickerson   +6 more
doaj   +1 more source

Differential treatment of bipolar disorder with old and new antiepileptic drugs [PDF]

open access: yes, 1998
Although lithium remains the preferred medication for bipolar disorders, new investigations suggest that only 60 to 80% of patients have a good response with a classical presentation.
Berger, M.   +4 more
core   +1 more source

Dynamic exponential utility indifference valuation

open access: yes, 2005
We study the dynamics of the exponential utility indifference value process C(B;\alpha) for a contingent claim B in a semimartingale model with a general continuous filtration.
Mania, Michael, Schweizer, Martin
core   +2 more sources

Manic/hypomanic symptoms induced by aripiprazole [PDF]

open access: yes, 2010
Aripiprazol é um antipsicótico atípico (AAt) frequentemente indicado para o tratamento agudo da mania, assim como para quadros mistos de transtorno bipolar (TB) tipo I e para o tratamento de manutenção do TB tipo I.
MORENO, Ricardo Alberto   +2 more
core   +3 more sources

Differences between unipolar mania and bipolar‐I disorder: Evidence from nine epidemiological studies

open access: yesBipolar Disorders, 2018
Although clinical evidence suggests important differences between unipolar mania and bipolar‐I disorder (BP‐I), epidemiological data are limited. Combining data from nine population‐based studies, we compared subjects with mania (M) or mania with mild ...
J. Angst   +22 more
semanticscholar   +1 more source

Assessing positive and negative valence systems to refine animal models of bipolar disorders: the example of GBR 12909-induced manic phenotype

open access: yesScientific Reports, 2022
Bipolar disorders are defined by recurrences of depressive and manic episodes. The pathophysiology is still unknown, and translating clinical symptoms into behaviors explorable in animal models is challenging.
Mathilde Bigot   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy